FDA warning letter targets Medtronic drug system issues; U.N. takes steps on controlled substances;

> The FDA has sent Medtronic a warning letter over problems related to the manufacture of a number of its products, including motor corrosion in one of its drug infusion systems. FDA warning letter 

> Concerned about the number of controlled substances now showing up on Internet pharmacy sites, the United Nations International Narcotics Control Board (INCB) is working on a system that would allow companies to access import and export authorizations electronically. Item 

> The Indian Department of Industrial Policy and Promotion (DIPP) has been asked to consider allowing foreign investors to buy up to 49% percent of existing pharmaceutical companies when the majority of ownership will remain Indian. Story 

> United Drug, a pharmaceutical and healthcare services group, has picked up the U.K. and U.S. clinical supply business of Bilcare for €61 million ($75.3 million). Release 

> Ess Dee Aluminum, which makes packaging for drugmakers like Pfizer ($PFE) and AstraZeneca ($AZN), says its plan to reopen an India Foils plant near Kolkata, India, hit a snag because it is having problems wrapping up its lease renewal. Story 

And Finally... Despite the fact that Australia's pharmaceutical, medical and scientific device industries have seen greater export growth than any other manufacturing sectors in the last decade, they receive only cursory mention in a new report on the importance of the country's manufacturing industry. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.